ArticleJournal of biological engineering2025
Efflux pump knockout minimizes crosstalk and boosts response in transcription factor-based biosensors.
Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors.Analytical science advances · 2026Review
- Using enantioselective biosensors to evolve asymmetric biocatalysts.Nature chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCellular transport systems are key determinants of intracellular molecule concentrations and can be utilized to modulate the responsiveness of transcription factor (TF)-based biosensors. Efflux pumps facilitate the export of small molecules; therefore, their activity can directly compromise the accuracy of biosensor-based assays. We engineered a cellular export machinery to enhance the responsiveness and reduce crosstalk of a DmpR-based biosensor, which employs the phenol-responsive TF DmpR to detect intracellular phenolic ligands but is affected by ligand diffusion between cells. To overcome this limitation, efflux pump genes were knocked out to minimize ligand diffusion and improve signal fidelity.
resultsAmong the efflux pumps tested, deletion of mdtA was found to promote effective intracellular accumulation of phenolic compounds. This strategy not only increased biosensor sensitivity by up to 19-fold but also reduced false positives during enzyme screening by suppressing intercellular diffusion of enzymatic products. In the mock library experiment, the proportion of false positives relative to the total positive cells was 74% in the wild-type strain, whereas it was only 5% in the ΔmdtA strain. To demonstrate the applicability of this approach to an enzyme screening platform, we targeted penicillin G acylase (PGA), an enzyme useful for producing semi-synthetic antibiotics. Knockout of mdtA effectively reduced false positives during flow cytometry-based high-throughput screening. Using this biosensor platform, several PGA variants with improved catalytic activity were successfully identified from a random mutagenesis library.
conclusionsOverall, host engineering to adjust cellular conditions and ligand concentrations provides a versatile approach to enhance the sensitivity, precision, and efficiency of single-cell-based enzyme screening platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.